EUVIMEDEUVIMED entdecken
Crossref

Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients

G Sotolongo iD, J L Poisson

Transfusion · 2023

DOI: 10.1111/trf.17529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von G Sotolongo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Duke University Hospital, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anemia, Aplastic, Primary Myelofibrosis, Blood Group Antigens, Anemia, Hemolytic, Autoimmune. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Red blood cell (RBC) alloimmunization (AI) is a well‐known complication of RBC transfusions, which results in the formation of alloantibodies to non‐self antigens on donor RBCs, putting patients at risk of transfusion‐related complications. The rate of AI with RBC transfusions in the general hospitalized population is estimated to be 2%–3%. However, some patients who are deemed “transfusion‐dependent” require regular transfusions of blood products due to persistently low cell counts, putting them at even greater risk of RBC AI and increased morbidity. However, few studies currently exist investigating RBC AI in some transfusion‐dependent patient populations, e.g., aplastic anemia (AA) and myelofibrosis (MF). Study Design and Methods We conducted a 5‐year retrospective review to investigate the prevalence of RBC AI, alloantibody incidence, and the number of RBC transfusions in AA and MF patients, who received RBC transfusions within our hospital system.

Results

During the study period, 64 AA and 93 MF patients received 1301 and 2766 RBC transfusions, respectively. Compared to the RBC AI rate in the generalized hospitalized patient population (1%–2%), patients with AA and MF had an increased rate of RBC AI incidence rate at 14.1% and 12.9%, respectively. Furthermore, patients with primary MF demonstrated an isolated increased RBC AI incidence rate of 13.3%. The most common alloantibodies produced were anti‐E and anti‐K.

Discussion

Within our institution, patients with AA and MF had increased incidence rates of RBC AI compared to the general hospitalized patient population and may benefit from an antigen‐matched protocol to minimize AI‐related complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticPrimary MyelofibrosisBlood Group AntigensAnemia, Hemolytic, AutoimmuneTransfusion ReactionHumansIsoantibodiesErythrocytes

Stichwörter der Autor:innen

RBC transfusionimmunohematology (RBC serology, blood groups)transfusion complications-non infectious

Substanzen

IsoantibodiesBlood Group Antigens

Autor:innen und Institutionen

  • Department of Pathology, Duke University Hospital, Durham, North Carolina, USA.

ORCID-Profile: G Sotolongo

Zitieren

APA

Sotolongo, G., & Poisson, J. L. (2023). Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients. Transfusion. https://doi.org/10.1111/trf.17529

Vancouver

Sotolongo G, Poisson JL. Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients. Transfusion. 2023. doi:10.1111/trf.17529

BibTeX
@article{Sotolongo2023,
  author = {Sotolongo, G and Poisson, J L},
  title = {Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17529}
}
Kostenlos starten →